UCAM dental, Clinica odontologica universitaria
Murcia, 30008, Spain
NCT Number: NCT06613776
This clinical trial aims to evaluate the impact of antibiotics on inflammation and pain in patients who have undergone mandibular third molar surgery. The primary research questions are:
1. Do antibiotics reduce pain following third molar surgery? 2. Do antibiotics influence facial swelling and the patient's ability to open their mouth? 3. Do antibiotics affect the levels of a specific inflammatory marker in saliva post-surgery?
Participants will be randomly assigned to receive either antibiotic capsules or placebo capsules. The study will include the following procedures:
Medication: Participants will take four capsules (either antibiotics or placebo) as part of their standard surgical care.
Saliva Samples: Saliva samples will be collected at three time points: before surgery, 24 hours after surgery, and 7 days post-surgery.
Measurements: Facial swelling and mouth opening will be assessed by the investigator at each time point.
By comparing the outcomes between the antibiotic and placebo groups, researchers aim to determine the effectiveness of antibiotics in managing post-surgical inflammation and pain.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Murcia, 30008, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
4 capsules of amoxicillin 500mg, 2 grams in total, one hour before surgery
4 empty capsules of amoxicillin 500mg (placebo), one hour before surgery
Time frame: From the first visit immediately after surgery to the last visit, 6 days.
Pain levels are assessed using a Visual Analog Scale (VAS) and a 10-point scale at several intervals: immediately after surgery, at 6 hours, 12 hours, and 24 hours post-surgery, and daily at 17:00 until the 6th day post-surgery. On this scale, 0 indicates no pain, while 10 represents the worst pain the patient has ever experienced.
Time frame: From the initial visit before surgery to the final visit 7 days post-surgery, at 7 days
Using a metal ruler, measure the maximum distance (in millimeters) between the incisal edge of the maxillary incisor and the lower incisor. The researcher will evaluate the maximum mouth opening at four time points: before surgery, immediately after surgery, 24 hours post-surgery, and 7 days post-surgery. The change in maximum mouth opening will be calculated by comparing the pre-surgery measurement with each subsequent measurement. Fewer changes are favorable.
Time frame: From the day of surgery to the last visit, at 7 days
Facial swelling is assessed using a tape-measuring method. The patient sits upright at a 90˚ angle with their mandible at rest. Three facial measurements are taken:
Line A: Distance from the tragus to the corner of the mouth Line B: Distance from the tragus to the soft tissue pogonion Line C: Distance from the outer corner of the eye to the angle of the mandible The facial measurement formula is ((A + B + C) / 3). Facial swelling (%) is calculated as ([postoperative measurement on T2 - preoperative measurement]/preoperative measurement) *100 Less facial swelling is favorable.
Universidad Católica San Antonio de Murcia
Other
Evaluation of the Effect of Antibiotic Prophylaxis on Inflammatory Factor in Salivary Samples After Third Molars Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details